Search

Your search keyword '"Klink, Barbara"' showing total 502 results

Search Constraints

Start Over You searched for: Author "Klink, Barbara" Remove constraint Author: "Klink, Barbara"
502 results on '"Klink, Barbara"'

Search Results

1. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts

2. Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification

4. Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification

5. Identification of Epigenetically Regulated Genes Distinguishing Intracranial from Extracranial Melanoma Metastases

6. Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis

7. Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe

8. Newborn screening programs for spinal muscular atrophy worldwide: Where we stand and where to go

9. Genetic counselling legislation and practice in cancer in EU Member States

10. Genetic counselling legislation and practice in cancer in EU Member States.

11. Exploiting a metabolic vulnerability in brain tumour stem cells using a brain-penetrant drug with safe profile

12. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology

13. Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma

14. AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion

15. The landscape of chromothripsis across adult cancer types

17. Supplementary Patient Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

18. Data from Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

19. Supplementary Table S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

20. Supplementary Tables S1-S7 from Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

21. Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

22. Supplementary Figure S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

23. Supplementary Figures S1-S10 from Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

24. Supplementary Methods from Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers

25. Supplementary Table S2 from An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells

26. Data from An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells

27. Supplementary Figures S1-S10 from An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells

28. Supplementary Data from The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity

29. Supplementary Methods and Reference from An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells

30. Glioblastoma-instructed microglia transit to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts

33. Defective homologous recombination DNA repair as therapeutic target in advanced chordoma

34. Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia

35. Sensitization of Patient-Derived Colorectal Cancer Organoids to Photon and Proton Radiation by Targeting DNA Damage Response Mechanisms

36. Proteogenomic analysis reveals RNA as an important source for tumor-agnostic neoantigen identification correlating with T-cell infiltration

37. CASP9 germline mutation in a family with multiple brain tumors

38. Author Correction: Variants in exons 5 and 6 of ACTB cause syndromic thrombocytopenia

42. Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids

43. Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures

44. The histone demethylase UTX regulates stem cell migration and hematopoiesis

45. Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids

46. Precision oncology based on omics data: The NCT Heidelberg experience

47. HBOC multi-gene panel testing: comparison of two sequencing centers

49. Understanding the new BRD4‐related syndrome: Clinical and genomic delineation with an international cohort study

50. Deciphering Human Glioblastoma Invasion Using a Developmental Mature Rat Brain Organoid Model

Catalog

Books, media, physical & digital resources